New test aims to match brain cancer patients with better drugs
NCT ID NCT06620380
Summary
This study is testing a personalized approach to find better drug treatments for cancer that has spread to the brain (brain metastases). Researchers will take a small sample of a patient's tumor during surgery and quickly test many different drugs on it in the lab to see which ones work best against that specific cancer. The goal is to see if using this test to guide treatment leads to better survival and quality of life compared to standard treatment choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cantonal Hospital St Gallen
NOT_YET_RECRUITINGSankt Gallen, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Basel
NOT_YET_RECRUITINGBasel, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Zurich
RECRUITINGZurich, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.